Literature DB >> 12086161

Functional long-term changes in patients with spondylarthropathy.

S Heikkilä1, J V Viitanen, H Kautiainen, M Kauppi.   

Abstract

The objective of the study was to determine the long-term functional outcome of chronic spondylarthropathy (SpA) when measured by various functional indices. This information is important in the planning of long-term intervention studies and selection of the best follow-up methods. The study group consisted of 65 patients (21 women and 44 men) with SpA. Their mean age was 49 years and the mean age from diagnosis was 12 years. They completed several questionnaires (developed for the evaluation of functional capacity or the state of health of patients with SpA) at the beginning of the study and 3 years later. The questionnaires were: the Bath Ankylosing Spondylitis Functional Index (BASFI), the Dougados Functional Index (DFI), the Health Assessment Questionnaire for Spondylarthropathies (HAQ-S), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Patient Global Assessment (BAS-G) and Stiffness-VAS (on a visual analogue scale). We also asked the patients to inform us if something had occurred in their lives during the follow-up that might have affected their health. Most of the indices (BASFI, DFI, BASDAI, BAS-G and Stiffness-VAS, but not HAQ-S) showed a statistically significant reduction in the functional capacity or state of health of the patients during the follow-up. Many factors occurring during the 3-year period may have influenced the results of the indices. The natural course of the functional capacity of patients with SpA appears to be one of impairment, when evaluated using these indices. Our experience also showed that it is very difficult to separate any effect of a single treatment intervention (e.g. rehabilitation) in a long-term follow-up study, as so many interfering factors, e.g. life events and health-related factors, may affect the follow-up population over several years.

Entities:  

Mesh:

Year:  2002        PMID: 12086161     DOI: 10.1007/s10067-002-8270-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters.

Authors:  Sefika Konca; Dilek Keskin; Deniz Cılız; Hatice Bodur; Bülent Sakman
Journal:  Rheumatol Int       Date:  2011-12-11       Impact factor: 2.631

Review 2.  Exercise therapy for spondyloarthritis: a systematic review.

Authors:  Tom O'Dwyer; Finbar O'Shea; Fiona Wilson
Journal:  Rheumatol Int       Date:  2014-02-19       Impact factor: 2.631

Review 3.  Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis.

Authors:  G H Louie; J D Reveille; M M Ward
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

4.  Spondyloarthritis is associated with poor function and physical health-related quality of life.

Authors:  Jasvinder A Singh; Vibeke Strand
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

Review 5.  Physical activity in spondyloarthritis: a systematic review.

Authors:  Tom O'Dwyer; Finbar O'Shea; Fiona Wilson
Journal:  Rheumatol Int       Date:  2014-10-10       Impact factor: 2.631

6.  Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG).

Authors:  Yasser El Miedany; Sally Youssef; Annie Mehanna; Naglaa Shebrya; Sherif Abu Gamra; Maha El Gaafary
Journal:  Clin Rheumatol       Date:  2008-01-05       Impact factor: 2.980

7.  Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis.

Authors:  Christel Nielsen; Ingemar F Petersson; Lennart T H Jacobsson; Anna Jöud
Journal:  Rheumatol Int       Date:  2017-09-06       Impact factor: 2.631

8.  Prevalence of chronic widespread pain in a population-based cohort of patients with spondyloarthritis - a cross-sectional study.

Authors:  Elisabeth Mogard; Ann Bremander; Elisabet Lindqvist; Stefan Bergman
Journal:  BMC Rheumatol       Date:  2018-04-05

9.  Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients.

Authors:  Zhiming Lin; Jieruo Gu; Peigen He; Jiesheng Gao; Xiaoxia Zuo; Zhizhong Ye; Fengmin Shao; Feng Zhan; Jinying Lin; Li Li; Yanlin Wei; Manlong Xu; Zetao Liao; Qu Lin
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.